Proton Therapy Systems Market is expected to reach US$ 2,945.14 million by 2030

Oncology Segment to Hold Significant Share of Proton Therapy Systems Market During 2022–2030   

According to our latest study on "Proton Therapy Systems Market Forecast to 2030 – Global Analysis – Setup Type, Application," the market value is expected to reach US$ 2,945.14 million by 2030 from US$ 1,262.45 million in 2022; it is estimated to record a CAGR of 11.2% during 2022–2030. The report emphasizes the key factors driving the market and prominent players' developments. Factors such as the rising demand for advanced treatments with the surging incidence of cancer, and increasing government support for proton therapy centers propel the market growth. However, the high cost and large area of proton therapy systems impede the growth of the market. Further, the adoption of personalized treatment approaches with technological advancements is expected to bring new proton therapy systems market trends in the coming years.

Over recent years, governments worldwide have recognized the potential of proton therapy to improve the outcomes of cancer treatment and have been increasingly supporting the establishment and expansion of proton therapy centers. They support the adoption of proton therapies through subsidies, funding, grants, and regulatory approvals. According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, and governments are under pressure to make effective and affordable treatment options available for their citizens. Governments also foresee the potential economic benefits of investing in proton therapy centers. These centers can stimulate economic growth by creating job opportunities and encouraging medical tourism. In recent years, several countries have announced plans to establish new proton therapy centers or expand existing facilities. For example, in the US, the National Cancer Institute (NCI) has been actively supporting research and development in proton therapy through grants and funding opportunities. In 2022, the Ontario Ministry of Health (Government of Ontario) announced a US$ 5 million "planning grant" to investigate the feasibility of building Ontario's first hospital-based proton radiation therapy center in downtown Canada. Similarly, in May 2023, India’s first government proton therapy facility commenced operation in the Tata Memorial Centre. Thus, the increasing government support for proton therapy centers globally reflects a growing recognition of this technology in cancer care, which boosts the proton therapy systems market growth.

Proton Therapy Systems Market, by Geography, 2022 (%)

Source: The Insight Partners Analysis

Proton therapy systems are highly capital-intensive, limiting their adoption across the world. The setup and operation of these centers require significant capital investment. A single-room system may cost US$ 30–50 million. The multi-gantry proton systems may cost up to US$ 300 million and are usually installed only in large hospitals and university systems. Therefore, the high capital investment required for proton therapy systems is among the factors hindering the proton therapy systems market growth.

The “proton therapy systems market analysis” has been carried out by considering the following segments: setup type and application. By setup type, the market is bifurcated into single-room and multi-room. The multi-room segment held a larger market share in 2022. The single-room segment is anticipated to register a higher CAGR during the forecast period. The market, by application, is categorized into brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, and others. The brain and central nervous system cancer segment held the largest proton therapy systems market share in 2022. It is further anticipated to register the highest CAGR during the forecast period.

Proton Therapy Systems Market, by Geography:

The geographic scope of the proton therapy systems market report entails North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

In 2022, North America held the largest proton therapy systems market share. The growing adoption of the latest medical device technologies, the high prevalence of cancer, and product innovations by key players contribute to the expansion of the proton therapy systems market size in North America. Similarly, Asia Pacific is expected to record the highest CAGR during the forecast period owing to the increasing number of cancer cases and rising healthcare expenditure in major countries in the region.

Apart from factors driving the market, the proton therapy systems market report emphasizes key developments by prominent players. Varian Medical Systems Inc, Sumitomo Heavy Industries Ltd, Hitachi Ltd, Ion Beam Applications SA, Mevion Medical Systems, Provision Healthcare LLC, ProTom International, Optivus Proton Therapy Inc, Advanced Oncotherapy plc, and B dot Medical Inc are among the prominent players contributing to the proton therapy systems market progress. These companies have been implementing various strategies that contribute to their growth and lead to various changes in the market. Organic strategies implemented by them include product launches, expansions, and product approvals, while inorganic strategies include collaborations and partnerships.

A few of the recent developments in the global market, as per the company press releases, are mentioned below:

• In December 2023, Nationwide Children’s Hospital and The Ohio State University Comprehensive Cancer Center started the US$100 million, 55,000 square foot proton therapy center, the first treatment facility in central Ohio offering this highly targeted form of radiation therapy for the treatment of complex tumors that cannot be removed through surgery.
• In October 2021, IBA (Ion Beam Applications SA) launched the world’s first online platform for proton therapy. The new interactive platform, Campus, was unveiled through webinars in October 2021. 

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com